Management of children with acute post-viral cough: a primary care experience with levodropropizine

Gian L Marseglia1,2, Daniele Veraldi2, Giorgio Ciprandi3

  • 1Pediatric Clinic, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

Minerva Pediatrics
|October 31, 2024
PubMed

Insights

Levodropropizine effectively reduces cough intensity and frequency in children suffering from acute post-viral cough (APVC). This safe treatment also improves sleep and daily activities for both children and their parents.

Area of Science:

  • Pediatrics
  • Pharmacology
  • Respiratory Medicine

Background:

  • Acute post-viral cough (APVC) significantly impacts children's quality of life.
  • Effective antitussive management is crucial for APVC.
  • Levodropropizine is recognized as a safe and effective peripheral antitussive agent.

Purpose of the Study:

  • To evaluate the efficacy and safety of levodropropizine in treating APVC in children.
  • To assess the impact of levodropropizine on cough symptoms, sleep, and daily activities.

Main Methods:

  • Retrospective observational study involving 92 children with APVC.
  • Treatment with levodropropizine for up to seven days.
  • Evaluation of cough intensity/frequency, sleep, daily activities, and adverse events.

Main Results:

  • Levodropropizine demonstrated significant reduction in cough intensity and frequency in most pediatric patients.
  • Improvements were observed in children's and parents' sleep quality and engagement in school/play activities.
  • The treatment was well-tolerated with a high level of parental satisfaction.

Conclusions:

  • Levodropropizine is an effective and safe therapeutic option for managing acute post-viral cough in pediatric populations.
  • The study supports levodropropizine's role in improving symptom burden and quality of life for children with APVC.
Abstract

Related Concept Videos

Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
177
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
353
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
103
Upper Respiratory Drugs: Decongestants01:27

Upper Respiratory Drugs: Decongestants

Decongestants are a class of medications used primarily to alleviate nasal congestion, a common symptom resulting from allergies, colds, sinusitis, and other upper respiratory tract infections. These drugs work by activating α-adrenergic receptors, constricting small blood vessels in the nasal membranes. This action results in the opening of clogged nasal passages, thereby facilitating sinus drainage and relieving congestion.
Most decongestants are readily available over-the-counter in...
167
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
182
Acute Pharyngitis01:30

Acute Pharyngitis

Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
450